Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation
Conditions: Extracorporeal Membrane Oxygenation Complication Interventions: Drug: bivalirudin Sponsors: Xiaotong Hou Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials
A Study on the Impact of Bivalirudin Usage During PCI for High-risk Plaques on Post-PCI Coronary Microcirculation.
Condition: Coronary Microvascular Dysfunction Interventions: Drug: Bivalirudin; Drug: standard heparin Sponsor: Peking University First Hospital Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 9, 2023 Category: Research Source Type: clinical trials
BivaLirudin versUS Heparin in Extracorporeal Membrane Oxygenation
Condition: Extracorporeal Membrane Oxygenation Complication Interventions: Drug: Unfractionated heparin; Drug: Bivalirudin Sponsor: Sydney Local Health District Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2023 Category: Research Source Type: clinical trials
